Mercaptopurine
NDC Package 69076-913-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mercaptopurine is a medication used to treat a certain type of cancer (acute lymphocytic leukemia). Marketed by Quinn Pharmaceuticals, this product is identified by NDC 69076-913 and is authorized under FDA application NDA009053.

Identification & Billing

NDC Package Code
69076-913-25
Package Description
250 TABLET in 1 BOTTLE, PLASTIC
Product Code
69076-913
11-Digit Billing Format
69076091325
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
250 EA

Clinical Specifications

Proprietary Name
Mercaptopurine
Dosage Form
-
Usage Information
This medication is used to treat a certain type of cancer (acute lymphocytic leukemia). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. Talk to the doctor about the risks and benefits of mercaptopurine, especially when used in children and young adults.

Regulatory & Marketing

Labeler Name
Quinn Pharmaceuticals
FDA Application #
NDA009053
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
10-05-2016
End Marketing Date
10-31-2024
Listing Expiration
10-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69076-913). Click a package code to view its specific billing and regulatory data.

69076-913-02
25 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69076-913-25 identifies a specific commercial package of 250 tablet in 1 bottle, plastic of Mercaptopurine, labeled by Quinn Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Quinn Pharmaceuticals on October 05, 2016. The current certification is valid through October 31, 2024.

What are the primary indications for this medication?

This medication is used to treat a certain type of cancer (acute lymphocytic leukemia). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. Talk to the doctor about the risks and benefits of mercaptopurine, especially when used in children and young adults.

How is this Quinn Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69076091325. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 250 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69076-913-25
11-Digit CMS (5-4-2)
69076-0913-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.